Results 191 to 200 of about 23,828 (263)

Galectin-3 promotes FBXL5-dependent ubiquitination and degradation of YAP1 to constrain colorectal cancer growth. [PDF]

Front Immunol
Zeng X, Mak TK, Li N, Wang J, Huang Z, Lu W.   +5 more
europepmc   +1 more source

Different contributions of YAP1 and TAZ in the regulation of GIST tumorigenic properties. [PDF]

Cell Commun Signal
Pezzati I, Hammoum T, Teko-Agbo CA, Konate K, Beranger M, Vivès E, Chibon F, Faure S, de Santa Barbara P, Serrano C, Deshayes S, Boisguérin P.   +11 more
europepmc   +1 more source

YAP1 Dysfunction Promotes Molecular Properties Linked to Breast Cancer Susceptibility. [PDF]

Cancer Prev Res (Phila)
Fresques T, Lopez JC, Hussey D, Miyano M, Garbe JC, Hinz S, Sayaman RW, Li A, Schmolze D, Van Bedford S, Stampfer MR, LaBarge MA.   +11 more
europepmc   +1 more source

YAP1 in control: how RNA networks and protein modifications shape its function and therapeutic targetability. [PDF]

Mol Cancer
Li J, Zeng X, Hu E, Zhou H, Huang W.
europepmc   +1 more source

FGFR1/YAP1 signaling in endothelial cells drives renal fibrosis and offers a therapeutic target. [PDF]

Front Pharmacol
Jiang X, Ren Y, Yan M, Li M, Cao H, Shao F.   +5 more
europepmc   +1 more source

The YAP1-NPM1 nuclear complex regulates MYC and reveals a targetable oncogenic node. [PDF]

iScience
Dwead AM, Al-Mathkour MM, Khanov M, Akbas E, Cinar B.   +4 more
europepmc   +1 more source

Rewiring transcriptional plasticity: the case for dual YAP1 and TAZ targeting in gastric cancer peritoneal metastases. [PDF]

Cancer Heterog Plast
Kumar R.
europepmc   +1 more source

YAP1 converts circELP2-mediated biochemical signals to mechanical forces through promoting cytoskeleton remodeling in pulmonary fibrosis. [PDF]

Int J Biol Sci
Li R, Zhang S, Zhang J, Zhang H, Wang Y, Lv C, Liu B, Ren L, Song X, Wang F.   +9 more
europepmc   +1 more source

Immunoexpression profile of LATS2 and YAP1 and its clinicopathological relevance in oral tongue squamous cell carcinoma. [PDF]

Oral Maxillofac Surg
Rocha Torres OKM, Borges ALA, da Costa LM, Colares DF, da Silveira ÉJD, da Miguel MCC.   +5 more
europepmc   +1 more source

Targeting NPSR1-mediated Hippo-YAP1 dysregulation suppresses gastric cancer progression. [PDF]

Cell Mol Life Sci
Qin W, Ma M, Fang W, Wang X, Yu B.
europepmc   +1 more source